Jefferies Group LLC Pulmonx Corp Call Options Transaction History

Jefferies Group LLC

  • $10.2 Billion
  • Q3 2022

Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2022

May 16, 2022
SELL
$21.13 - $35.65 $929,720 - $1.57 Million
-44,000 Closed
0 $0
Q4 2021

Sep 21, 2023
BUY
$29.72 - $45.1 $832,160 - $1.26 Million
28,000 Added 175.0%
44,000 $1.41 Million
Q4 2021

Feb 14, 2022
BUY
$29.72 - $45.1 $832,160 - $1.26 Million
28,000 Added 175.0%
44,000 $1.41 Million
Q3 2021

Sep 21, 2023
BUY
$35.98 - $44.48 $575,680 - $711,680
16,000 New
16,000 $575,000
Q3 2021

Nov 15, 2021
BUY
$35.98 - $44.48 $575,680 - $711,680
16,000 New
16,000 $576,000

Others Institutions Holding LUNG

# of Institutions
124
Shares Held
30.8M
Call Options Held
1.2K
Put Options Held
1.2K
View Full List

About Pulmonx Corp

LUNG Quotes by TradingView
  • Ticker LUNG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,268,400
  • Market Cap $236M
  • Description
  • Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...
More about LUNG
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email